37 research outputs found
STEREOFUNCTIONAL FEATURES OF MOTHER-PLACENTA-FETUS SYSTEM IN OPTIMIZATION OF COMPLEX TREATMENT OF THREATENING PRETERM LABOR
Purpose: improving the efficiency of complex treatment of threatened abortion.Materials and Methods: The study involved 299 primigravidas. The I clinical group consisted of 78 women with threatened miscarriage receiving combination therapy (standard medication and acupuncture). The II clinical group consisted of 76 women receiving combined medication and acupuncture to our improved method. In the III clinical group - 71 women with threatened miscarriage, which received only standard medical therapy. In the IV (control group) there were 74 pregnant women with physiological pregnancy.Results: It has been proven that the lateral stimulation of biologically active points of acupuncture taking into account the factor of placental laterality in the utero-placental-fetal complex initiate functional processes accompanied by an increase right asymmetry of utero-placental blood flow and uterine activity, and improvement of the fetus condition.Summary: We proved that in unilateral acupuncture impact to the placenta, processes of functional symmetry in the utero-placental-fetal complex in women with threatened termination of pregnancy are replaced by functional asymmetry of processes that improve the condition of the fetu
ΠΠ΅ΡΡΠΎΠ½ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ ΡΡΠ΅Ρ Π·Π°ΡΡΠ°Ρ Π² ΡΠΏΡΠ°Π²Π»Π΅Π½ΡΠ΅ΡΠΊΠΎΠΌ ΡΡΠ΅ΡΠ΅ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΉ
In the modern economic conditions, the rational planning of costs and the complex process optimization are essential requirements to all organizations. Knowledge of costs is needed to correctly assess the economic performance of an organization. Competent and timely correction of tariffs for the obligatory medical insurance and rationalization of the requested financing of the medical organization depends on this assessment. In the present study, we analyze various methods of personalized cost accounting: the ratio of costs to charges (RCC); relative value unit (RVU); time-driven activity-based costing (TDABC), and the possibility of their adaptation to the specific needs of medical organizations. The personalized cost accounting incorporated into a medical information system allows for controlling, planning and carrying out a close internal management of financial activity. This function helps decision-makers: control the use of funds for medical care provision; increase the efficiency of management decisions; justify the prices of paid medical services; define the deficit and surplus work units; analyze the treatment cost for each patient, considering the diagnosis, method of treatment, age and other classification signs, including the reference to specialized departments; reduce the unnecessary βpaperβ work load on the medical personnel; model the future needs of the organization in accordance with the planned changes in the hospitalization policy; optimize, control and plan the budget with regard to the established standards of financial expenses. Implementation of this approach is expected to increase the work efficiency in most medical organizations and the entire healthcare system.Π ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
ΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΡΠ»ΠΎΠ²ΠΈΡΡ
Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠ½ΠΎΠΉ ΡΠ΅ΡΡΠΎΠΉ Π΄Π»Ρ Π²ΡΠ΅Ρ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΉ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠ°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ΅ ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ°ΡΡ
ΠΎΠ΄ΠΎΠ² ΠΈ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½Π°Ρ ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΡ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ². ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ Π·Π°ΡΡΠ°Ρ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ Π²ΡΡΠ°Π±ΠΎΡΠ°ΡΡ ΠΏΡΠ°Π²ΠΈΠ»ΡΠ½ΡΡ ΠΎΡΠ΅Π½ΠΊΡ ΡΡΠΎΠ²Π½Ρ ΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ. ΠΡ Π΄Π°Π½Π½ΠΎΠΉ ΠΎΡΠ΅Π½ΠΊΠΈ Π·Π°Π²ΠΈΡΠΈΡ Π³ΡΠ°ΠΌΠΎΡΠ½Π°Ρ ΠΈ ΡΠ²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½Π°Ρ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΡΠΎΠ²ΠΊΠ° ΡΠ°ΡΠΈΡΠΎΠ² ΠΎΠ±ΡΠ·Π°ΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠ³ΠΎ ΡΡΡΠ°Ρ
ΠΎΠ²Π°Π½ΠΈΡ ΠΈ ΠΎΠ±ΠΎΡΠ½ΠΎΠ²Π°Π½Π½ΠΎΡΡΡ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΠ³ΠΎ ΡΠΈΠ½Π°Π½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ. Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡΡΡ Π°Π½Π°Π»ΠΈΠ· ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΠΏΠ΅ΡΡΠΎΠ½ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΡΡΠ΅ΡΠ° Π·Π°ΡΡΠ°Ρ: ΠΌΠ΅ΡΠΎΠ΄Π° ΡΠΎΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΡ Π·Π°ΡΡΠ°Ρ ΠΊ ΠΏΡΠΈΠ±ΡΠ»ΠΈ, ΠΌΠ΅ΡΠΎΠ΄Π° Π΅Π΄ΠΈΠ½ΠΈΡΡ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΡΠΎΠΈΠΌΠΎΡΡΠΈ, ΡΠΈΡΡΠ΅ΠΌΠ° ΡΡΠ΅ΡΠ° Π·Π°ΡΡΠ°Ρ ΠΏΠΎ Π²ΠΈΠ΄Π°ΠΌ Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΈ Π΅Π΅ ΠΌΠΎΠ΄ΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ Time-driven ABC (TDABS), Π° ΡΠ°ΠΊΠΆΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΈΡ
Π°Π΄Π°ΠΏΡΠ°ΡΠΈΠΈ Π΄Π»Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΡΠ΅Π»Π΅ΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΉ. Π‘ΠΈΡΡΠ΅ΠΌΠ° ΠΏΠ΅ΡΡΠΎΠ½ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΡΡΠ΅ΡΠ° Π·Π°ΡΡΠ°Ρ, Π²ΠΊΠ»ΡΡΠ΅Π½Π½Π°Ρ Π² ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΡΡ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΡΡ ΡΠΈΡΡΠ΅ΠΌΡ, ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎ ΠΊΠΎΠ½ΡΡΠΎΠ»ΠΈΡΠΎΠ²Π°ΡΡ, ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°ΡΡ ΠΈ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡ Π²Π½ΡΡΡΠ΅Π½Π½ΠΈΠΉ ΡΠΈΠ½Π°Π½ΡΠΎΠ²ΡΠΉ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ. ΠΡΠ° ΡΡΠ½ΠΊΡΠΈΡ ΠΏΠΎΠΌΠΎΠ³Π°Π΅Ρ Π»ΠΈΡΠ°ΠΌ, ΠΏΡΠΈΠ½ΠΈΠΌΠ°ΡΡΠΈΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π² ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ, Π² ΡΠ΅ΡΠ΅Π½ΠΈΠΈ ΡΠ»Π΅Π΄ΡΡΡΠΈΡ
Π·Π°Π΄Π°Ρ: ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΡΡΠ΅Π΄ΡΡΠ² Π½Π° ΠΎΠΊΠ°Π·Π°Π½ΠΈΠ΅ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ; ΡΡΠΈΠ»Π΅Π½ΠΈΠ΅ Π΄Π΅ΠΉΡΡΠ²Π΅Π½Π½ΠΎΡΡΠΈ ΠΈ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠΏΡΠ°Π²Π»Π΅Π½ΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅ΡΠ΅Π½ΠΈΠΉ; ΠΎΠ±ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠ΅Π½Ρ ΠΏΠ»Π°ΡΠ½ΡΡ
ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΡΡΠ»ΡΠ³; ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π΄Π΅ΡΠΈΡΠΈΡΠ½ΡΡ
ΠΈ ΠΏΡΠΎΡΠΈΡΠΈΡΠ½ΡΡ
ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠΉ; Π°Π½Π°Π»ΠΈΠ· Π΄Π°Π½Π½ΡΡ
ΠΎ ΡΡΠΎΠΈΠΌΠΎΡΡΠΈ ΡΠ»ΡΡΠ°Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΊΠ°ΠΆΠ΄ΠΎΠ³ΠΎ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° Ρ ΡΡΠ΅ΡΠΎΠΌ Π΄ΠΈΠ°Π³Π½ΠΎΠ·Π°, ΠΌΠ΅ΡΠΎΠ΄Π° Π»Π΅ΡΠ΅Π½ΠΈΡ, Π²ΠΎΠ·ΡΠ°ΡΡΠ° ΠΈ Π΄ΡΡΠ³ΠΈΡ
ΠΊΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠ², Π² Ρ.Ρ. Π² ΡΠ°Π·ΡΠ΅Π·Π΅ ΠΏΡΠΎΡΠΈΠ»ΡΠ½ΡΡ
ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠΉ; ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ Β«Π±ΡΠΌΠ°ΠΆΠ½ΠΎΠΉΒ» Π½Π°Π³ΡΡΠ·ΠΊΠΈ Π½Π° ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΠΉ ΠΏΠ΅ΡΡΠΎΠ½Π°Π»; ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΡΠ΄ΡΡΠΈΡ
ΠΏΠΎΡΡΠ΅Π±Π½ΠΎΡΡΠ΅ΠΉ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ Π² ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΠΈΠΈ Ρ ΠΏΠ»Π°Π½ΠΈΡΡΠ΅ΠΌΡΠΌΠΈ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡΠΌΠΈ ΡΡΡΡΠΊΡΡΡΡ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ; ΠΎΠΏΡΠΈΠΌΠΈΠ·Π°ΡΠΈΡ ΡΠ°ΡΡ
ΠΎΠ΄ΠΎΠ², ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ ΠΈ ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Ρ ΡΡΠ΅ΡΠΎΠΌ ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π½ΡΡ
Π½ΠΎΡΠΌΠ°ΡΠΈΠ²ΠΎΠ² ΡΠΈΠ½Π°Π½ΡΠΎΠ²ΡΡ
Π·Π°ΡΡΠ°Ρ. Π Π΅Π°Π»ΠΈΠ·Π°ΡΠΈΡ Π΄Π°Π½Π½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ° ΡΠ²Π»ΡΠ΅ΡΡΡ Π°ΠΊΡΡΠ°Π»ΡΠ½ΡΠΌ ΠΈ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΡΠΌ ΠΈΠ½ΡΡΡΡΠΌΠ΅Π½ΡΠΎΠΌ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ, ΠΊΠ°ΠΊ ΡΠ°ΠΌΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΈ, ΡΠ°ΠΊ ΠΈ Π²ΡΠ΅ΠΉ ΡΠΈΡΡΠ΅ΠΌΡ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ Π² ΡΠ΅Π»ΠΎΠΌ
Seasonal periodicity of melatonin exchange and hormonal status of pregnant women in dependence on fetus sex
Objective: to study melatonin metabolism and hormonal status of pregnant women in different seasons of the year, depending on the sex of the fetus. Materials and methods: 538 women were examined at the time of physiological gestation of 37-40 weeks. The first group β 286 pregnant women with female fetuses and the second group β 254 pregnant with male fetuses. Estimation of the hormonal status included the determination of the level of cortisol, estradiol, adrenocorticotropic hormone, progesterone, testosterone in the blood and melatonin in the urine of pregnant women. Results: the level of 6-sulphatoxymelatonin in the morning urine, regardless of the sex of the fetus, was higher in the seasons of the year with the predominance of the dark time of the day. Absolute levels of 6-sulphatoxymelatonin in urine in all women in 37-40 weeks of gestation were the lowest in the light-saturated summer and spring months of the year, while in the winter period its parameters were maximal. Melatonin production was statistically significantly higher in pregnant women with female fetuses during the fall and winter periods of the year. Regardless of the time of the year, in pregnant women with female fetuses, the absolute levels of estradiol and progesterone were higher than in the case of the male fetus. The highest values in the case of the female fetus were noted in the spring. Testosterone production was significantly higher in pregnant women with male fetuses mainly in the spring season. Stress resistance of pregnant women was higher in the summer months. Depending on the βsex of the fetusβ factor, stress hormones in the summer had the highest values in pregnant women with male fetuses. Conclusions: the sex of the fetus is a significant factor affecting the seasonal variability of melatonin production, sexual and stress hormones in pregnant women due to the formation of the specificity of the systemic signaling between the maternal and the fetal organism in the dynamics of pregnancy
THE EFFECT OF LIGHT DEPRIVATION ON FUNCTIONAL PROCESSES IN THE SYSTEM βMOTHER β PLACENTA β FETUSβ IN CASE OF THREATENING PRETERM BIRTH AND ITS CLINICAL SIGNIFICANCE
Objective: to study the nature of uterine contractile activity, hormonal status, melatonin metabolism, blood flow in the uterine and fetal vessels, and the state of the fetus wellbeing before and after standard drug treatment and combination therapy involving the additional use of light deprivation. Materials and methods: a total of 547 women with threatening preterm birth were examined at 28 β 35 weeks of pregnancy. Among these, 198 pregnant women received standard therapy and 196 women received combined treatment, medical along with light deprivation. The control group consisted of 153 women with physiological pregnancy. We used cardiotocography to study the contractile activity of the uterus and the fetal cardiac rhythm, enzyme-linked immunosorbent assay methods to study the expression of hormones (ACTH, cortisol, progesterone, estriol, placental lactogen) in the blood and 6-sulfatoxymelatonin in the urine of pregnant women. Results: threatening preterm labor is accompanied by an increase in the level of generalized (bilateral) uterine activity, a decrease in the level of melatonin and an increase in the level of stress hormones. After using standard drug therapy, there is a suppression of any form of uterine activity, which leads to a deterioration of the fetus state in 30,2% of women, while combined therapy increases the level of melatonin, decreases the activity of stress-liberating subsystems of the motherβs body, and increases the level of right-sided uterine contractions that contribute to maintaining functional activity of the uteroplacental βpumpβ, contributing to the prevention of fetal distress. Conclusions: theΒ studies indicate an improvement in the therapeutic effect with using light deprivation, as an additional method for tocolysis in women with the threat of premature birth
Daily periodicity of labor in pregnant women in physiological and complicated pregnancy depending on the sex of the fetus
Objective: the study aimed to reveal the daily periodicity of labor, the nature of melatonin metabolism, and the outcome of childbirth in women with a physiological and complicated pregnancy, depending on the sex of the fetus.Materials and methods: to study the chronophysiological characteristics of birth outcomes depending on fetal sex, 1 980 birth histories and stories of newborns were analyzed. The neonates were born between January 1 and December 31, 2016, in a maternity ward of the Federal State Budgetary Educational Institution of Higher Education βRostGMUβ of the Ministry of Health of Russia. Melatonin production was identified by the level of urinary excretion of 6-sulfatoxymelatonin (6-SM) (its main metabolite) examining the morning portion of the urine of women by the ELISA method (at 8 am 3 ml of urine were collected in Eppendorf tube).Results: it was revealed that fetal sex modulated the activity of the central regulatory mechanisms responsible for the daily period functional processes in the female body and the initiation of labor. The largest number of spontaneous births by male fetuses occurred in the early evening before midnight when daily illumination was decreased, while the birth of girls was observed more often in the period from midnight to early morning. At the same time, mothers of boys had lower production of melatonin compared to that of girlsβ mothers.Conclusions. The peculiarities of labor and birth complications associated with the sex of the fetus were identified
ΠΠΠ’ΠΠΠΠΠΠΠΠ― ΠΠ¦ΠΠΠΠ ΠΠ€Π€ΠΠΠ’ΠΠΠΠΠ‘Π’Π ΠΠ‘ΠΠΠΠ¬ΠΠΠΠΠΠΠ― ΠΠΠΠ§ΠΠΠΠ Π€ΠΠΠΠ ΠΠΠΠΠ¦ΠΠΠ‘ΠΠΠ₯ ΠΠ ΠΠΠΠΠΠΠ¦ΠΠ
Since recently, a number of normative legal acts aimed at increasing the salaries of medical professionals in the Russian Federation have been implemented. As these decisions are not supported by increasing the financial bases of medical organizations, those institutions may develop the accounts payable status. Under these conditions, the efficient usage of hospital beds may bring a financial relief to these medical institutions. The present study addresses the assessment of bed usage and suggests a well-rationalized set of methods to evaluate and characterize the bed usage efficiency. The main indicators of this efficiency are: the number of beds, the bed turnover, the number of hospitalized patients, the average length of hospital stay per patient per year, and the average bed occupancy per year. In this study, we analyze the available data on the hospital bed usage taken from the annual statistical information published by the Ministry of Health of the Russian Federation. Using the method of chain substitutions we have found ways to improve the quality of medical services and reduce economic losses in medical organizations. Our results recommend implementing periodical analysis of the hospital bed usage both in general and in specialized clinics. The results also suggest mobilizing more reserves to increase the performance of hospital bed usage, mainly by increasing the bed occupancy in specialized round-the-clock hospitals. It is recommended to conduct a comparative analysis of the planned vs factual bed usage, to restructure the hospital setting with a possible change in the number of specialized beds, to optimize the routing of patients when providing primary medical care, as well as routing the patients when providing emergency service including emergency specialized medical care.ΠΡΠ½ΠΎΠ²Π½ΠΎΠΉ ΠΏΡΠΈΡΠΈΠ½ΠΎΠΉ Π΄Π»Ρ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠΎΠ΅ΡΠ½ΠΎΠ³ΠΎ ΡΠΎΠ½Π΄Π° ΡΡΠ°Π»Π° Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΠΌΠΈ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡΠΌΠΈ ΡΡΠ΄Π° Π½ΠΎΡΠΌΠ°ΡΠΈΠ²Π½ΡΡ
ΠΏΡΠ°Π²ΠΎΠ²ΡΡ
Π°ΠΊΡΠΎΠ², Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΡ
Π½Π° ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ Π·Π°ΡΠ°Π±ΠΎΡΠ½ΠΎΠΉ ΠΏΠ»Π°ΡΡ ΡΠΎΡΡΡΠ΄Π½ΠΈΠΊΠ°ΠΌ ΡΡΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠΉ Π±ΡΠ΄ΠΆΠ΅ΡΠ½ΠΎΠΉ ΡΡΠ΅ΡΡ, Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΠΏΡΠ΅ΠΆΠ½Π΅Π³ΠΎ ΡΡΠΎΠ²Π½Ρ ΡΠΈΠ½Π°Π½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ, ΡΡΠΎ ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΠ΅Ρ ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈ ΡΠΎΡΡΡ ΠΊΡΠ΅Π΄ΠΈΡΠΎΡΡΠΊΠΎΠΉ Π·Π°Π΄ΠΎΠ»ΠΆΠ΅Π½Π½ΠΎΡΡΠΈ ΡΡΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠΉ. Π ΡΡΠ°ΡΡΠ΅ ΡΠ°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ ΠΎΡΠ΅Π½ΠΊΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠΎΠ΅ΡΠ½ΠΎΠ³ΠΎ ΡΠΎΠ½Π΄Π° ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΉ, Π²ΡΡΠ²Π»Π΅Π½Π° ΠΎΠ±ΠΎΡΠ½ΠΎΠ²Π°Π½Π½Π°Ρ ΡΠΎΠ²ΠΎΠΊΡΠΏΠ½ΠΎΡΡΡ ΠΏΡΠΈΠ΅ΠΌΠΎΠ² ΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΡΡΡΡΠΊΡΡΡΡ ΠΎΡΠ΅Π½ΠΎΡΠ½ΠΎΠΉ Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ. ΠΡΠ½ΠΎΠ²Π½ΡΠΌΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠΌΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠΎΠ΅ΠΊ ΡΠ²Π»ΡΡΡΡΡ: ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ ΠΊΠΎΠ΅ΠΊ, ΠΎΠ±ΠΎΡΠΎΡ ΠΊΠΎΠΉΠΊΠΈ, ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π±ΠΎΠ»ΡΠ½ΡΡ
, ΡΡΠ΅Π΄Π½ΡΡ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΏΡΠ΅Π±ΡΠ²Π°Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° Π½Π° ΠΊΠΎΠΉΠΊΠ΅ Π² Π³ΠΎΠ΄Ρ (Π² Π΄Π½ΡΡ
), ΡΡΠ΅Π΄Π½ΡΡ Π·Π°Π½ΡΡΠΎΡΡΡ ΠΊΠΎΠΉΠΊΠΈ Π² Π³ΠΎΠ΄Ρ (Π² Π΄Π½ΡΡ
), ΡΡΠ΅Π΄Π½Π΅Π΅ Π²ΡΠ΅ΠΌΡ ΠΏΡΠΎΡΡΠΎΡ ΠΊΠΎΠΉΠΊΠΈ. Π‘ ΡΠ΅Π»ΡΡ ΠΎΡΠ΅Π½ΠΊΠΈ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠ΅ΠΉ ΠΌΠ΅ΡΠΎΠ΄Π° ΠΎΡΠ΅Π½ΠΊΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠΎΠ΅ΡΠ½ΠΎΠ³ΠΎ ΡΠΎΠ½Π΄Π° Π² ΡΡΠ°ΡΡΠ΅ ΠΏΡΠΎΠΈΠ·Π²Π΅Π΄Π΅Π½Ρ ΡΠ°ΡΡΠ΅ΡΡ ΠΈ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΏΠΎ ΠΎΡΠ½ΠΎΠ²Π½ΡΠΌ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠΌ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠΎΠ΅ΠΊ Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ ΠΎΡΠΊΡΡΡΡΡ
Π΄Π°Π½Π½ΡΡ
(Π΅ΠΆΠ΅Π³ΠΎΠ΄Π½Π°Ρ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΡ, ΠΏΡΠ±Π»ΠΈΠΊΡΠ΅ΠΌΠ°Ρ ΠΠΈΠ½Π·Π΄ΡΠ°Π²ΠΎΠΌ Π Π€). ΠΠ° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠΎΠ΅ΡΠ½ΠΎΠ³ΠΎ ΡΠΎΠ½Π΄Π° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΡΠ΅ΠΏΠ½ΡΡ
ΠΏΠΎΠ΄ΡΡΠ°Π½ΠΎΠ²ΠΎΠΊ Π² ΡΠ΅Π»ΡΡ
ΡΠΎΠ²Π΅ΡΡΠ΅Π½ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠ³ΠΎ ΠΎΠ±ΡΠ»ΡΠΆΠΈΠ²Π°Π½ΠΈΡ ΠΈ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΡΠ΅ΡΡ Π² ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡΡ
ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄ΡΠ΅ΡΡΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡ Π°Π½Π°Π»ΠΈΠ· ΠΈ ΠΎΡΠ΅Π½ΠΊΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠΎΠ΅ΡΠ½ΠΎΠ³ΠΎ ΡΠΎΠ½Π΄Π° ΠΊΠ°ΠΊ Π² ΡΠ΅Π»ΠΎΠΌ, ΡΠ°ΠΊ ΠΈ ΠΏΠΎ ΠΎΡΠ΄Π΅Π»ΡΠ½ΡΠΌ ΠΏΡΠΎΡΠΈΠ»ΡΠΌ, ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°ΡΡ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠ΅Π·Π΅ΡΠ²Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠΎΠ΅ΡΠ½ΠΎΠ³ΠΎ ΡΠΎΠ½Π΄Π°, Π³Π»Π°Π²Π½ΡΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, Π·Π° ΡΡΠ΅Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΡΡΠ΅Π΄Π½Π΅ΠΉ Π·Π°Π½ΡΡΠΎΡΡΠΈ ΠΊΠΎΠ΅ΠΊ ΠΏΠΎ ΠΎΡΠ΄Π΅Π»ΡΠ½ΡΠΌ ΠΏΡΠΎΡΠΈΠ»ΡΠΌ ΠΊΡΡΠ³Π»ΠΎΡΡΡΠΎΡΠ½ΡΡ
ΠΊΠΎΠ΅ΠΊ ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ°, ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡ ΡΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΠ»Π°Π½ΠΎΠ²ΡΡ
ΠΈ ΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΊΠΎΠ΅ΡΠ½ΠΎΠ³ΠΎ ΡΠΎΠ½Π΄Π°, ΡΠ΄Π΅Π»ΡΡΡ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΡΡΡΡΠΊΡΡΡΠ½ΠΎΠΉ ΠΏΠ΅ΡΠ΅ΡΡΡΠΎΠΉΠΊΠ΅ ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ° Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΠΌ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π° ΠΏΡΠΎΡΠΈΠ»ΡΠ½ΡΡ
ΠΊΠΎΠ΅ΠΊ, ΡΠ΄Π΅Π»ΡΡΡ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΠΌΠ°ΡΡΡΡΡΠΈΠ·Π°ΡΠΈΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΏΡΠΈ ΠΎΠΊΠ°Π·Π°Π½ΠΈΠΈ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΠΊΠΎ-ΡΠ°Π½ΠΈΡΠ°ΡΠ½ΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ, ΡΠ΄Π΅Π»ΡΡΡ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΠΌΠ°ΡΡΡΡΡΠΈΠ·Π°ΡΠΈΠΈ ΠΏΡΠΈ ΠΎΠΊΠ°Π·Π°Π½ΠΈΠΈ ΡΠΊΠΎΡΠΎΠΉ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ ΡΠΊΠΎΡΠΎΠΉ ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ, ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ
ΠΠ±Π·ΠΎΡ Π·Π°ΡΡΠ±Π΅ΠΆΠ½ΠΎΠ³ΠΎ ΠΎΠΏΡΡΠ° ΡΠΈΠ½Π°Π½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈΠ½Π½ΠΎΠ²Π°ΡΠΈΠΎΠ½Π½ΡΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ ΡΠ΅Ρ Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ
The article presents a review of the foreign approaches to the mechanisms of financing of medical help and innovative medical technologies with the description of the implemented financial mechanisms of stimulation of innovations in foreign systems of public healthcare. Since the system of payment for diagnosis-related groups (DRG) does not contribute to the implementation of innovations in the medical practice, the majority of countries apply additional mechanisms of financing of innovative technologies in public healthcare such as single and additional payments, and target financing that was initially not associated with a DRG model.Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ ΠΎΠ±Π·ΠΎΡ Π·Π°ΡΡΠ±Π΅ΠΆΠ½ΡΡ
ΠΏΠΎΠ΄Ρ
ΠΎΠ΄ΠΎΠ² ΠΊ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠ°ΠΌ ΡΠΈΠ½Π°Π½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ ΠΈ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΈΠ½Π½ΠΎΠ²Π°ΡΠΈΠΎΠ½Π½ΡΡ
ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ, Ρ ΠΎΠΏΠΈΡΠ°Π½ΠΈΠ΅ΠΌ ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΠ΅ΠΌΡΡ
ΡΠΈΠ½Π°Π½ΡΠΎΠ²ΡΡ
ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΡΡΠΈΠΌΡΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈΠ½Π½ΠΎΠ²Π°ΡΠΈΠΉ Π² Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΠΈ Π·Π° ΡΡΠ±Π΅ΠΆΠΎΠΌ. Π ΡΠ²ΡΠ·ΠΈ Ρ ΡΠ΅ΠΌ, ΡΡΠΎ ΠΎΠΏΠ»Π°ΡΠ° ΠΏΠΎ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌ Π³ΡΡΠΏΠΏΠ°ΠΌ (ΠΠ‘Π) Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ Π½Π΅ ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΠ΅Ρ Π²Π½Π΅Π΄ΡΠ΅Π½ΠΈΡ ΠΈΠ½Π½ΠΎΠ²Π°ΡΠΈΠΉ Π² ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΡΡ ΠΏΡΠ°ΠΊΡΠΈΠΊΡ, Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²ΠΎ ΡΡΡΠ°Π½ ΠΏΡΠΈΠΌΠ΅Π½ΡΡΡ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΡ ΡΠΈΠ½Π°Π½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈΠ½Π½ΠΎΠ²Π°ΡΠΈΠΎΠ½Π½ΡΡ
ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ Π² Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΠΈ, ΡΠ°ΠΊΠΈΠ΅ ΠΊΠ°ΠΊ ΠΎΡΠ΄Π΅Π»ΡΠ½ΡΠ΅ ΠΈ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΠΏΠ»Π°ΡΠ΅ΠΆΠΈ, ΡΠ΅Π»Π΅Π²ΠΎΠ΅ ΡΠΈΠ½Π°Π½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅, ΠΈΠ·Π½Π°ΡΠ°Π»ΡΠ½ΠΎ Π½ΠΈΠΊΠ°ΠΊ Π½Π΅ ΡΠ²ΡΠ·Π°Π½Π½ΡΠ΅ Ρ ΠΌΠΎΠ΄Π΅Π»ΡΡ ΠΠ‘Π
Genetic and expression studies of SMN2 gene in Russian patients with spinal muscular atrophy type II and III
<p>Abstract</p> <p>Background</p> <p>Spinal muscular atrophy (SMA type I, II and III) is an autosomal recessive neuromuscular disorder caused by mutations in the survival motor neuron gene (<it>SMN1</it>). <it>SMN2 </it>is a centromeric copy gene that has been characterized as a major modifier of SMA severity. SMA type I patients have one or two <it>SMN2 </it>copies while most SMA type II patients carry three <it>SMN2 </it>copies and SMA III patients have three or four <it>SMN2 </it>copies. The <it>SMN1 </it>gene produces a full-length transcript (FL-SMN) while <it>SMN2 </it>is only able to produce a small portion of the FL-SMN because of a splice mutation which results in the production of abnormal SMNΞ7 mRNA.</p> <p>Methods</p> <p>In this study we performed quantification of the <it>SMN2 </it>gene copy number in Russian patients affected by SMA type II and III (42 and 19 patients, respectively) by means of real-time PCR. Moreover, we present two families consisting of asymptomatic carriers of a homozygous absence of the <it>SMN1 </it>gene. We also developed a novel RT-qPCR-based assay to determine the FL-SMN/SMNΞ7 mRNA ratio as SMA biomarker.</p> <p>Results</p> <p>Comparison of the <it>SMN2 </it>copy number and clinical features revealed a significant correlation between mild clinical phenotype (SMA type III) and presence of four copies of the <it>SMN2 </it>gene. In both asymptomatic cases we found an increased number of <it>SMN2 </it>copies in the healthy carriers and a biallelic <it>SMN1 </it>absence. Furthermore, the novel assay revealed a difference between SMA patients and healthy controls.</p> <p>Conclusions</p> <p>We suggest that the <it>SMN2 </it>gene copy quantification in SMA patients could be used as a prognostic tool for discrimination between the SMA type II and SMA type III diagnoses, whereas the FL-SMN/SMNΞ7 mRNA ratio could be a useful biomarker for detecting changes during SMA pharmacotherapy.</p
Π‘ΠΎΠ²Π΅ΡΡΠ΅Π½ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΎΠΏΠ»Π°ΡΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ ΠΏΡΠΈ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΌ Π²ΠΈΡΡΡΠ½ΠΎΠΌ Π³Π΅ΠΏΠ°ΡΠΈΡΠ΅ Π‘ Π² ΡΠ°ΠΌΠΊΠ°Ρ ΡΠ΅Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΡΠΎΠ³ΡΠ°ΠΌΠΌΡ Π³ΠΎΡΡΠ΄Π°ΡΡΡΠ²Π΅Π½Π½ΡΡ Π³Π°ΡΠ°Π½ΡΠΈΠΉ Π±Π΅ΡΠΏΠ»Π°ΡΠ½ΠΎΠ³ΠΎ ΠΎΠΊΠ°Π·Π°Π½ΠΈΡ Π³ΡΠ°ΠΆΠ΄Π°Π½Π°ΠΌ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π½Π° 2023 Π³ΠΎΠ΄ ΠΈ Π½Π° ΠΏΠ»Π°Π½ΠΎΠ²ΡΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ 2024β2025 Π³ΠΎΠ΄ΠΎΠ²
Background. In 2021, new clinical guidelines for the treatment of chronic hepatitis C virus (HCV) in adults were published that did not contain interferon drug therapy regimens. Current therapy of chronic HCV is based on modern drugs of direct-acting antivirals (DAA). In this regard, the model of diagnosis-related groups (DRG) with the use of interferon-containing drugs as etiotropic therapy, which has been in effect until now, has lost its relevance and cannot be used to pay for cases of medical care for chronic HCV within the framework of the Program of State Guarantees of Free Medical Care to Citizens for 2023 and for the planning period of 2024β2025 (PSG). Objective: to improve the DRG model to pay for medical care for chronic HCV in a day hospital based on current clinical recommendations.Material and methods. Regulatory legal documents on the subject of the study, proposals and expert opinions of specialists, as well as feedback from public organizations, including patients, regarding the payment of medical care for chronic HCV, sent as part of a public discussion of the draft PSG, were studied. For the calculations were used: the current version of the clinical recommendations "Chronic viral hepatitis C"; impersonal personalized information of the database of registers of bills for payment for medical care for 2020β2021; the state register of manufacturers' maximum selling prices for medicines included in the list of vital and essential drugs.Results. A DRG model was developed to pay for medical care during drug therapy of chronic HCV, including for children. When calculating the model, the cost of medicines, patient days and the principles of accounting for the duration of hospitalization were updated.Conclusion. The developed DRG model to pay for medical care for chronic HCV in a day hospital with the use of drug therapy regimens with DAA recommended by clinical guidelines, including for children with HCV, contributes to improving the effectiveness of the system of payment for medical care provided as part of the implementation of the PSG and accessibility of medical care for this contingent of patients.ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. Π 2021 Π³. ΠΎΠΏΡΠ±Π»ΠΈΠΊΠΎΠ²Π°Π½Ρ Π½ΠΎΠ²ΡΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΈ ΠΏΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π²ΠΈΡΡΡΠ½ΠΎΠ³ΠΎ Π³Π΅ΠΏΠ°ΡΠΈΡΠ° Π‘ (Π₯ΠΠΠ‘) Ρ Π²Π·ΡΠΎΡΠ»ΡΡ
, Π² ΠΊΠΎΡΠΎΡΡΡ
ΠΎΡΡΡΡΡΡΠ²ΡΡΡ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½ΠΎΠ²ΡΠ΅ ΡΡ
Π΅ΠΌΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ. ΠΠΊΡΡΠ°Π»ΡΠ½Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ Π₯ΠΠΠ‘ Π±Π°Π·ΠΈΡΡΠ΅ΡΡΡ Π½Π° ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ
ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΈΡΡΡΠ½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°Ρ
ΠΏΡΡΠΌΠΎΠ³ΠΎ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ (ΠΠΠΠ). Π ΡΡΠΎΠΉ ΡΠ²ΡΠ·ΠΈ ΠΌΠΎΠ΄Π΅Π»Ρ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π³ΡΡΠΏΠΏ (ΠΠ‘Π) Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΡΡΠΈΠΎΡΡΠΎΠΏΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΈΠ½ΡΠ΅ΡΡΠ΅ΡΠΎΠ½ΠΎΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ², Π΄Π΅ΠΉΡΡΠ²ΡΡΡΠ°Ρ Π΄ΠΎ Π½Π°ΡΡΠΎΡΡΠ΅Π³ΠΎ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ, ΡΡΡΠ°ΡΠΈΠ»Π° Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ ΠΈ Π½Π΅ ΠΌΠΎΠΆΠ΅Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°ΡΡΡΡ Π΄Π»Ρ ΠΎΠΏΠ»Π°ΡΡ ΡΠ»ΡΡΠ°Π΅Π² ΠΎΠΊΠ°Π·Π°Π½ΠΈΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ ΠΏΡΠΈ Π₯ΠΠΠ‘ Π² ΡΠ°ΠΌΠΊΠ°Ρ
ΡΠ΅Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΡΠΎΠ³ΡΠ°ΠΌΠΌΡ Π³ΠΎΡΡΠ΄Π°ΡΡΡΠ²Π΅Π½Π½ΡΡ
Π³Π°ΡΠ°Π½ΡΠΈΠΉ Π±Π΅ΡΠΏΠ»Π°ΡΠ½ΠΎΠ³ΠΎ ΠΎΠΊΠ°Π·Π°Π½ΠΈΡ Π³ΡΠ°ΠΆΠ΄Π°Π½Π°ΠΌ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π½Π° 2023 Π³ΠΎΠ΄ ΠΈ Π½Π° ΠΏΠ»Π°Π½ΠΎΠ²ΡΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ 2024β2025 Π³ΠΎΠ΄ΠΎΠ² (ΠΠΠ).Π¦Π΅Π»Ρ: ΡΠΎΠ²Π΅ΡΡΠ΅Π½ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΠ‘Π Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ Π΄Π»Ρ ΠΎΠΏΠ»Π°ΡΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ ΠΏΡΠΈ Π₯ΠΠΠ‘ Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
Π΄Π½Π΅Π²Π½ΠΎΠ³ΠΎ ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ° Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ Π΄Π΅ΠΉΡΡΠ²ΡΡΡΠΈΡ
ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΉ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ·ΡΡΠ΅Π½Ρ Π½ΠΎΡΠΌΠ°ΡΠΈΠ²Π½ΡΠ΅ ΠΏΡΠ°Π²ΠΎΠ²ΡΠ΅ Π΄ΠΎΠΊΡΠΌΠ΅Π½ΡΡ ΠΏΠΎ ΡΠ΅ΠΌΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ, ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½ΠΈΡ ΠΈ ΡΠΊΡΠΏΠ΅ΡΡΠ½ΡΠ΅ ΠΌΠ½Π΅Π½ΠΈΡ ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΡΡΠΎΠ², Π° ΡΠ°ΠΊΠΆΠ΅ ΠΎΡΠ·ΡΠ²Ρ ΠΎΠ±ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΉ, Π²ΠΊΠ»ΡΡΠ°Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡΠΊΠΈΠ΅, Π² ΡΠ°ΡΡΠΈ ΠΎΠΏΠ»Π°ΡΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ ΠΏΡΠΈ Π₯ΠΠΠ‘, Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΠ΅ Π² ΡΠ°ΠΌΠΊΠ°Ρ
ΠΎΠ±ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΠΎΠ±ΡΡΠΆΠ΄Π΅Π½ΠΈΡ ΠΏΡΠΎΠ΅ΠΊΡΠ° ΠΠΠ. ΠΠ»Ρ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΡΠ°ΡΡΠ΅ΡΠΎΠ² ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΠΈΡΡ: Π°ΠΊΡΡΠ°Π»ΡΠ½Π°Ρ Π²Π΅ΡΡΠΈΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΉ Β«Π₯ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ Π²ΠΈΡΡΡΠ½ΡΠΉ Π³Π΅ΠΏΠ°ΡΠΈΡ Π‘Β», ΠΎΠ±Π΅Π·Π»ΠΈΡΠ΅Π½Π½ΡΠ΅ ΠΏΠ΅ΡΡΠΎΠ½ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΡΠ²Π΅Π΄Π΅Π½ΠΈΡ Π±Π°Π·Ρ ΡΠ΅Π΅ΡΡΡΠΎΠ² ΡΡΠ΅ΡΠΎΠ² Π½Π° ΠΎΠΏΠ»Π°ΡΡ Π·Π° ΠΎΠΊΠ°Π·Π°Π½ΠΈΠ΅ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π·Π° 2020β2021 Π³Π³., Π³ΠΎΡΡΠ΄Π°ΡΡΡΠ²Π΅Π½Π½ΡΠΉ ΡΠ΅Π΅ΡΡΡ ΠΏΡΠ΅Π΄Π΅Π»ΡΠ½ΡΡ
ΠΎΡΠΏΡΡΠΊΠ½ΡΡ
ΡΠ΅Π½ ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΡΠ΅Π»Π΅ΠΉ Π½Π° Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ, Π²ΠΊΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π² ΠΏΠ΅ΡΠ΅ΡΠ΅Π½Ρ ΠΆΠΈΠ·Π½Π΅Π½Π½ΠΎ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΡΡ
ΠΈ Π²Π°ΠΆΠ½Π΅ΠΉΡΠΈΡ
Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ².Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π° ΠΌΠΎΠ΄Π΅Π»Ρ ΠΠ‘Π Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ Π΄Π»Ρ ΠΎΠΏΠ»Π°ΡΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π₯ΠΠΠ‘, Π² Ρ.Ρ. Π΄Π»Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π΄Π΅ΡΡΠΊΠΎΠ³ΠΎ Π²ΠΎΠ·ΡΠ°ΡΡΠ°. ΠΡΠΈ ΡΠ°ΡΡΠ΅ΡΠ΅ ΠΌΠΎΠ΄Π΅Π»ΠΈ Π°ΠΊΡΡΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π° ΡΡΠΎΠΈΠΌΠΎΡΡΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ², ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎ-Π΄Π½Ρ ΠΈ ΠΏΡΠΈΠ½ΡΠΈΠΏΡ ΡΡΠ΅ΡΠ° Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½Π°Ρ ΠΌΠΎΠ΄Π΅Π»Ρ ΠΠ‘Π Π΄Π»Ρ ΠΎΠΏΠ»Π°ΡΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ ΠΏΡΠΈ Π₯ΠΠΠ‘ Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
Π΄Π½Π΅Π²Π½ΠΎΠ³ΠΎ ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ° Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΡΡ
Π΅ΠΌ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΠΠΠ, ΠΏΡΠ΅Π΄Π»Π°Π³Π°Π΅ΠΌΡΡ
ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΡΠΌΠΈ, Π² Ρ.Ρ. Π΄Π»Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ Π₯ΠΠΠ‘, ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΠ΅Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠΈΡΡΠ΅ΠΌΡ ΠΎΠΏΠ»Π°ΡΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ, ΠΎΠΊΠ°Π·ΡΠ²Π°Π΅ΠΌΠΎΠΉ Π² ΡΠ°ΠΌΠΊΠ°Ρ
ΡΠ΅Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΠΠ, ΠΈ Π΄ΠΎΡΡΡΠΏΠ½ΠΎΡΡΠΈ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ Π΄Π»Ρ Π΄Π°Π½Π½ΠΎΠ³ΠΎ ΠΊΠΎΠ½ΡΠΈΠ½Π³Π΅Π½ΡΠ° Π±ΠΎΠ»ΡΠ½ΡΡ